Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ARGAN INCAGX · Entity 3828 | Director · PRESIDENT AND CEO | June 15, 2026 | June 16, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ARGAN INC
Report date June 15, 2026 · Filed June 16, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 40,005 |
Ending reported balance
After 2026-06-16 transaction · row 5
5 source rows · reconciled sequenceRow 1 · 2026-06-15 · Sale · Disposed 9,993 · Balance 40,005 F1: On June 15, 2026, the Reporting Person sold 9,993 shares of the Issuer's common stock on the open market at an average price of $651.22 per share. Row 2 · 2026-06-16 · Exercise / conversion · Acquired 862 · Balance 40,867 F2: On June 16, 2026, the Reporting Person exercised the remaining portion of his stock option awarded on April 17, 2023 to purchase 1,666 shares of the Issuer's common stock at a price of $39.47 per share using the net settle method. Row 3 · 2026-06-16 · Exercise / conversion · Acquired 588 · Balance 41,455 F3: On June 16, 2026, the Reporting Person exercised a portion of his stock option awarded on April 16, 2024 to purchase 1,000 shares of the Issuer's common stock at a price of $61.22 per share using the net settle method. Row 4 · 2026-06-16 · Exercise / conversion · Acquired 430 · Balance 41,885 F4: On June 16, 2026, the Reporting Person exercised a portion of his stock option awarded on April 16, 2025 to purchase 667 shares of the Issuer's common stock at a price of $148.72 per share using the net settle method. Row 5 · 2026-06-16 · Sale · Disposed 1,880 · Balance 40,005 F5: On June 16, 2026 the Reporting Person sold 1,880 shares of the Issuer's common stock on the open market at an average price of $707.35 per share. |
| Option to Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $39.47 · Expires 2033-04-17 | Direct | 4,415 |
Reported balance
After 2026-06-16 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-06-16 · Exercise / conversion · Disposed 1,666 · Balance 4,415 F2: On June 16, 2026, the Reporting Person exercised the remaining portion of his stock option awarded on April 17, 2023 to purchase 1,666 shares of the Issuer's common stock at a price of $39.47 per share using the net settle method. |
| Option to Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $61.22 · Expires 2034-04-16 | Direct | 3,415 |
Reported balance
After 2026-06-16 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2026-06-16 · Exercise / conversion · Disposed 1,000 · Balance 3,415 F3: On June 16, 2026, the Reporting Person exercised a portion of his stock option awarded on April 16, 2024 to purchase 1,000 shares of the Issuer's common stock at a price of $61.22 per share using the net settle method. |
| Option to Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $148.72 · Expires 2035-04-16 | Direct | 2,748 |
Reported balance
After 2026-06-16 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2026-06-16 · Exercise / conversion · Disposed 667 · Balance 2,748 F4: On June 16, 2026, the Reporting Person exercised a portion of his stock option awarded on April 16, 2025 to purchase 667 shares of the Issuer's common stock at a price of $148.72 per share using the net settle method. |
Filing footnotes · ownership attribution and instrument terms
F1: On June 15, 2026, the Reporting Person sold 9,993 shares of the Issuer's common stock on the open market at an average price of $651.22 per share.
F2: On June 16, 2026, the Reporting Person exercised the remaining portion of his stock option awarded on April 17, 2023 to purchase 1,666 shares of the Issuer's common stock at a price of $39.47 per share using the net settle method.
F3: On June 16, 2026, the Reporting Person exercised a portion of his stock option awarded on April 16, 2024 to purchase 1,000 shares of the Issuer's common stock at a price of $61.22 per share using the net settle method.
F4: On June 16, 2026, the Reporting Person exercised a portion of his stock option awarded on April 16, 2025 to purchase 667 shares of the Issuer's common stock at a price of $148.72 per share using the net settle method.
F5: On June 16, 2026 the Reporting Person sold 1,880 shares of the Issuer's common stock on the open market at an average price of $707.35 per share.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 12, 2019 Filed Apr 16, 2019 14:26 UTC | ARGAN INC AGX · Entity 3828 | GrantPerformance-Based Restricted Stock Units · Derivative | 8,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001104659-19-021521 · a4.xml · derivative · entry 3 Watson David Hibbert · CIK 0001482442 · SVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,000 Underlying: Common Stock · 8,000 shares Expires not disclosed F3 · shares: On April 12, 2019, the Reporting Person was granted Performance-Based Restricted Stock Units (the "PBRSUs") in the target number of 8,000 shares (the "Target"), the vesting of which is subject to the percentile of the Total Stock Return ("TSR") of the Issuer's common stock over a three-year period, as determined by the Issuer's Board of Directors, versus the comparative TSRs of 12 peer public companies to be disclosed in the Issuer's 2019 Proxy Statement. Each PBRSU represents a contingent right to receive one share of the Issuer's common stock. The payout ratio of the Target, ranging from 0% to 200%, will depend on the degree of achievement of the percentile of the TSR. F4 · derivative.exercise_date: These PBRSUs are to vest in their entirety at the end of a three-year performance period as reported under footnote 3 above. F4 · derivative.expiration_date: These PBRSUs are to vest in their entirety at the end of a three-year performance period as reported under footnote 3 above. F5 · balance_after: As of the date of this filing, the total number of PBRSUs owned by the Reporting Person includes (a) a target number of 8,000 shares of PBRSUs granted on April 13, 2018, to vest in their entirety at the end of a three-year performance period; and (b) a target number of 8,000 shares of PBRSUs granted on April 12, 2019, to vest in their entirety at the end of a three-year performance period as reported under footnote 3 above. Read SEC document |
| April 12, 2019 Filed Apr 16, 2019 14:26 UTC | ARGAN INC AGX · Entity 3828 | GrantStock Option to purchase Common Stock · Derivative | 32,000 | $0.00 Strike: $50.30 | $0.00 |
DisclosureSEC source: 0001104659-19-021521 · a4.xml · derivative · entry 2 Watson David Hibbert · CIK 0001482442 · SVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,000 Underlying: Common Stock · 32,000 shares Expires 2029-04-12 F1 · shares: On April 12, 2019, the Reporting Person received 10-year options to purchase 32,000 shares of the Issuer's common stock with an exercise price of $50.30 per share. The options will vest ratably over three years on each anniversary of the grant date starting from 04/12/2020. F2 · balance_after: As of the date of this filing, the total number of options owned by the Reporting Person includes (a) options to acquire 30,000 shares of common stock at a price of $41.68 with Date Exercisable of 06/23/2017 and Expiration Date of 06/23/2026; (b) options to acquire 40,000 shares of common stock at a price of $64.25 per share with Date Exercisable of 04/06/2018 and Expiration Date of 04/06/2027; (c) options to acquire 32,000 shares of common stock at a price of $37.60 per share, subject to a three-year ratably vesting schedule, with Date Exercisable of 04/13/2019 and Expiration Date of 04/13/2028; and (d) options to acquire 32,000 shares of common stock at a price of $50.30 subject to the aforementioned three-year ratably vesting schedule with a Date Exercisable of 4/12/2020 and Expiration date of 4/12/2029. Read SEC document |
| April 13, 2018 Filed Apr 17, 2018 00:11 UTC | ARGAN INC AGX · Entity 3828 | GrantPerformance-Based Restricted Stock Units · Derivative | 8,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001104659-18-024299 · a4.xml · derivative · entry 3 Watson David Hibbert · CIK 0001482442 · SVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,000 Underlying: Common Stock · 8,000 shares Expires not disclosed F3 · shares: On April 13, 2018, the Reporting Person was granted Performance-Based Restricted Stock Units (the "PBRSUs") in the target number of 8,000 shares (the "Target"), the vesting of which is subject to the percentile of the Total Stock Return ("TSR") of the Issuer's common stock over a three-year period, as determined by the Issuer's Board of Directors, versus the comparative TSRs of 12 peer public companies to be disclosed in the Issuer's 2018 Proxy Statement. Each PBRSU represents a contingent right to receive one share of the Issuer's common stock. The payout ratio of the Target, ranging from 0% to 200%, will depend on the degree of achievement of the percentile of the TSR. F4 · derivative.exercise_date: These PBRSUs are to vest in their entirety at the end of a three-year performance period as reported under footnote 3 above. F4 · derivative.expiration_date: These PBRSUs are to vest in their entirety at the end of a three-year performance period as reported under footnote 3 above. Read SEC document |
| April 13, 2018 Filed Apr 17, 2018 00:11 UTC | ARGAN INC AGX · Entity 3828 | GrantStock Option to purchase Common Stock · Derivative | 32,000 | $0.00 Strike: $37.60 | $0.00 |
DisclosureSEC source: 0001104659-18-024299 · a4.xml · derivative · entry 2 Watson David Hibbert · CIK 0001482442 · SVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,000 Underlying: Common Stock · 32,000 shares Expires 2028-04-13 F1 · shares: On April 13, 2018, the Reporting Person received 10-year options to purchase 32,000 shares of the Issuer's common stock with an exercise price of $37.60 per share. The options will vest ratably over three years on each anniversary of the grant date starting from 04/13/2019. F2 · balance_after: As of the date of this filing, the total number of options owned by the Reporting Person includes (a) options to acquire 30,000 shares of common stock at a price of $41.68 with Date Exercisable of 06/23/2017 and Expiration Date of 06/23/2026; (b) options to acquire 40,000 shares of common stock at a price of $64.25 per share with Date Exercisable of 04/06/2018 and Expiration Date of 04/06/2027; and (c) options to acquire 32,000 shares of common stock at a price of $37.60 per share, subject to the aforementioned three-year ratably vesting schedule, with Date Exercisable of 04/13/2019 and Expiration Date of 04/13/2028. Read SEC document |
| April 17, 2017 Filed Apr 17, 2017 23:36 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionStock Option to purchase Common Stock · Derivative | 7,446 | $0.00 Strike: $33.85 | $0.00 |
DisclosureSEC source: 0001104659-17-023828 · a4.xml · derivative · entry 6 Watson David Hibbert · CIK 0001482442 · SVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,000 Underlying: Common Stock · 7,446 shares Expires 2026-04-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: On April 17, 2017, the Reporting Person exercised his stock option received on April 13, 2016 to purchase 7,446 shares of the Issuer's common stock at a price of $33.85 per share. F5 · balance_after: As of the date of this filing, the total number of options owned by the Reporting Person includes (a) options to acquire 30,000 shares of common stock at a price of $41.68 with Date Exercisable of 06/23/2017 and Expiration Date of 06/23/2026; and (b) options to acquire 40,000 shares of common stock at a price of $64.25 per share with Date Exercisable of 04/06/2018 and Expiration Date of 04/06/2027. Read SEC document |
| April 17, 2017 Filed Apr 17, 2017 23:36 UTC | ARGAN INC AGX · Entity 3828 | SaleCommon Stock | 6,446 | $65.07 | $419,441.22 |
DisclosureSEC source: 0001104659-17-023828 · a4.xml · nonDerivative · entry 4 Watson David Hibbert · CIK 0001482442 · SVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,700 F4 · shares: On April 17, 2017, the Reporting Person sold 6,446 shares of the Issuer's common stock on the open market at an average price of $65.07 per share. Read SEC document |
| April 17, 2017 Filed Apr 17, 2017 23:36 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionCommon Stock | 7,446 | $33.85 | $252,047.10 |
DisclosureSEC source: 0001104659-17-023828 · a4.xml · nonDerivative · entry 3 Watson David Hibbert · CIK 0001482442 · SVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,146 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: On April 17, 2017, the Reporting Person exercised his stock option received on April 13, 2016 to purchase 7,446 shares of the Issuer's common stock at a price of $33.85 per share. Read SEC document |
| April 13, 2017 Filed Apr 17, 2017 23:36 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionStock Option to purchase Common Stock · Derivative | 2,554 | $0.00 Strike: $33.85 | $0.00 |
DisclosureSEC source: 0001104659-17-023828 · a4.xml · derivative · entry 5 Watson David Hibbert · CIK 0001482442 · SVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,446 Underlying: Common Stock · 2,554 shares Expires 2026-04-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On April 13, 2017, the Reporting Person exercised his stock option received on April 13, 2016 to purchase 2,554 shares of the Issuer's common stock at a price of $33.85 per share. Read SEC document |
| April 13, 2017 Filed Apr 17, 2017 23:36 UTC | ARGAN INC AGX · Entity 3828 | SaleCommon Stock | 2,204 | $66.00 | $145,464.00 |
DisclosureSEC source: 0001104659-17-023828 · a4.xml · nonDerivative · entry 2 Watson David Hibbert · CIK 0001482442 · SVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,700 F2 · shares: On April 13, 2017, the Reporting Person sold 2,204 shares of the Issuer's common stock on the open market at an average price of $66.00 per share. Read SEC document |
| April 13, 2017 Filed Apr 17, 2017 23:36 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionCommon Stock | 2,554 | $33.85 | $86,452.90 |
DisclosureSEC source: 0001104659-17-023828 · a4.xml · nonDerivative · entry 1 Watson David Hibbert · CIK 0001482442 · SVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,904 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On April 13, 2017, the Reporting Person exercised his stock option received on April 13, 2016 to purchase 2,554 shares of the Issuer's common stock at a price of $33.85 per share. Read SEC document |
| April 06, 2017 Filed Apr 7, 2017 21:39 UTC | ARGAN INC AGX · Entity 3828 | GrantStock Option to purchase Common Stock · Derivative | 40,000 | $0.00 Strike: $64.25 | $0.00 |
DisclosureSEC source: 0001104659-17-022314 · a4.xml · derivative · entry 2 Watson David Hibbert · CIK 0001482442 · SVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock · 40,000 shares Expires 2027-04-06 F1 · shares: On April 6, 2017, the Reporting Person received 10-year options to purchase 40,000 shares of the Issuer's common stock with an exercise price of $64.25 per share. F2 · balance_after: As of the date of this filing, the total number of options owned by the Reporting Person includes (a) options to acquire 10,000 shares of common stock at a price of $33.85 per share with Date Exercisable of 04/13/2017 and Expiration Date of 04/13/2026; (b) options to acquire 30,000 shares of common stock at a price of $41.68 with Date Exercisable of 06/23/2017 and Expiration Date of 06/23/2026; and (c) options to acquire 40,000 shares of common stock at a price of $64.25 per share with Date Exercisable of 04/06/2018 and Expiration Date of 04/06/2027. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.